The use of radioisotope labels is ubiquitous in biochemistry, cell biology, drug discovery and numerous other fields, yet the approaches for detecting radioisotopes are more than four decades old. However, there is an unmet need for radioisotope detection materials that are more compatible with biological samples and that provide better temporal and spatial resolution. Scintillation Nanotechnologies develops and manufactures composite nanomaterials for detection of radioisotopes in biochemical and drug discovery applications. The proprietary composite nanomaterials provide a key enabling tool for established and new biochemical investigations that will directly impact human health. Scintillation Nanotechnologies has four products ready for immediate release to the market.